enVVeno Medical Investor Presentation November 2023

enVVeno Medical is developing innovative venous valve replacement devices to treat chronic venous insufficiency (CVI), a condition caused by valve failure in leg veins with no current effective treatments. The company is advancing its VenoValve® through a SAVVE U.S. pivotal trial and expects IDE approval for a non-surgical replacement device in Q4 2024, targeting combined U.S. markets of 6 million patients.